28/05/26

For biotech and start‑up teams balancing innovation with speed, a well‑defined Target Product Profile (TPP) is essential—yet challenging to develop when timelines are tight, data is evolving, and resources are limited.

Our workshop accelerates this process. In a structured, collaborative session, we work with you and our cross‑functional experts to translate your science into a clear, prioritized Target Product Profile that defines the intended product and provides the foundation for informed decision‑making from preclinical development through commercialization.

What you will learn

During the workshop, you develop a cohesive draft TPP aligned with your scientific and strategic objectives.
The session integrates perspectives from CMC, non-clinical and clinical development, regulatory affairs, and commercial strategy to ensure early cross-functional alignment.
Together, we identify key evidence gaps, potential risks, and priority development activities, giving you clear direction on where to focus next.

What you will walk away with

The outcome is a strategic document that supports internal planning, investor discussions, and early regulatory engagement, along with tailored recommendations outlining the most critical next steps for your development stage.

Who should attend

Co-founders and founders
COO
CSO
R&D Leaders

From start-ups, and early-stage biotechs

Location & Time

Plus Ultra Utrecht
Universiteitsweg 101
3584 CG Utrecht

Time 13.30 – 16.30

door Idalia Dlugosz